| The Epidemiology of Community-Acquired Clostridium difficile Infection: A Population-Based Study S Khanna, DS Pardi, SL Aronson, PP Kammer, R Orenstein, JL St Sauver, ... The American Journal of Gastroenterology 107 (1), 89-95, 2012 | 759 | 2012 |
| A Clinician's Primer on the Role of the Microbiome in Human Health and Disease S Khanna, PK Tosh Mayo Clinic Proceedings 89 (1), 107-114, 2014 | 374 | 2014 |
| A novel microbiome therapeutic increases gut microbial diversity and prevents recurrent Clostridium difficile infection S Khanna, DS Pardi, CR Kelly, CS Kraft, T Dhere, MR Henn, ... Journal of Infectious Diseases 214 (2), 173-181, 2016 | 354 | 2016 |
| Community-acquired Clostridium difficile infection: an increasing public health threat A Gupta, S Khanna Infect Drug Resist 7 (7), 63-72, 2014 | 322 | 2014 |
| Systematic review: colitis associated with anti‐CTLA‐4 therapy A Gupta, KM De Felice, EV Loftus Jr, S Khanna Alimentary pharmacology & therapeutics 42 (4), 406-417, 2015 | 316 | 2015 |
| The Epidemiology of Clostridium difficile Infection in Children: A Population-Based Study S Khanna, LM Baddour, WC Huskins, PP Kammer, WA Faubion, ... Clinical infectious diseases 56 (10), 1401-1406, 2013 | 263 | 2013 |
| The growing incidence and severity of Clostridium difficile infection in inpatient and outpatient settings S Khanna, DS Pardi Expert Review of Gastroenterology and Hepatology 4 (4), 409-416, 2010 | 218 | 2010 |
| Clostridium difficile Infection: New Insights Into Management S Khanna, DS Pardi Mayo Clinic Proceedings 87 (11), 1106-1117, 2012 | 186 | 2012 |
| Regulation of dendritic cells and macrophages by an anti-apoptotic cell natural antibody that suppresses TLR responses and inhibits inflammatory arthritis Y Chen, S Khanna, CS Goodyear, YB Park, E Raz, S Thiel, C Grönwall, ... The Journal of Immunology 183 (2), 1346-1359, 2009 | 180 | 2009 |
| Low Cure Rates in Controlled Trials of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection: A Systematic Review and Meta-analysis R Tariq, DS Pardi, MG Bartlett, S Khanna Clinical Infectious Diseases 68 (8), 1351-1358, 2019 | 177 | 2019 |
| Association of gastric acid suppression with recurrent Clostridium difficile infection: a systematic review and meta-analysis R Tariq, S Singh, A Gupta, DS Pardi, S Khanna JAMA Internal Medicine 177 (6), 784-791, 2017 | 176 | 2017 |
| 2019 update of the WSES guidelines for management of Clostridioides (Clostridium) difficile infection in surgical patients M Sartelli, S Di Bella, LV McFarland, S Khanna, L Furuya-Kanamori, ... World Journal of Emergency Surgery 14, 1-29, 2019 | 163 | 2019 |
| 2019 update of the WSES guidelines for management of Clostridioides (Clostridium) difficile infection in surgical patients M Sartelli, S Di Bella, LV McFarland, S Khanna, L Furuya-Kanamori, ... World Journal of Emergency Surgery 14, 1-29, 2019 | 163 | 2019 |
| 2019 update of the WSES guidelines for management of Clostridioides (Clostridium) difficile infection in surgical patients M Sartelli, S Di Bella, LV McFarland, S Khanna, L Furuya-Kanamori, ... World Journal of Emergency Surgery 14 (1), 8, 2019 | 163 | 2019 |
| The relationship between disease activity and quality of life in systemic lupus erythematosus S Khanna, H Pal, RM Pandey, R Handa Rheumatology 43 (12), 1536, 2004 | 159 | 2004 |
| Management of Clostridium difficile Infection in Inflammatory Bowel Disease: Expert Review from the Clinical Practice Updates Committee of the AGA Institute S Khanna, A Shin, CP Kelly Clinical Gastroenterology and Hepatology 15 (2), 166-174, 2017 | 153 | 2017 |
| Fecal Microbiota Transplantation Is Highly Effective in Real-World Practice: Initial Results From the FMT National Registry CR Kelly, EF Yen, AM Grinspan, SA Kahn, A Atreja, JD Lewis, TA Moore, ... Gastroenterology 160 (1), 183-192. e3, 2021 | 152 | 2021 |
| Fecal Microbiota Transplantation Is Highly Effective in Real-World Practice: Initial Results From the FMT National Registry CR Kelly, EF Yen, AM Grinspan, SA Kahn, A Atreja, JD Lewis, TA Moore, ... Gastroenterology 160 (1), 183-192. e3, 2021 | 152 | 2021 |
| Efficacy and safety of RBX2660 in PUNCH CD3, a phase III, randomized, double-blind, placebo-controlled trial with a Bayesian primary analysis for the prevention of recurrent … S Khanna, M Assi, C Lee, D Yoho, T Louie, W Knapple, H Aguilar, ... Drugs 82 (15), 1527-1538, 2022 | 150 | 2022 |
| Clostridioides difficile uses amino acids associated with gut microbial dysbiosis in a subset of patients with diarrhea EJ Battaglioli, VL Hale, J Chen, P Jeraldo, C Ruiz-Mojica, BA Schmidt, ... Science translational medicine 10 (464), eaam7019, 2018 | 149 | 2018 |
Darrell S Pardi在 mayo.edu 的电子邮件经过验证
